Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliance Certificate As Per Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2021.

 In terms of Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time please find attached herewith the Compliance Certificate duly signed by the Compliance Officer of the Company and Authorised Representative of Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company for the half year ended March 31, 2021.
16-04-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Declaration With Respect To Non - Applicability Of Large Corporate Framework Pursuant To SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26, 2018.

 With reference to SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 in respect of fund raising by issuance of Debt Securities by "Large Corporates" (LC), we hereby confirm that as on March 31, 2021, our Company, Mangalam Drugs and Organics Limited is not a Large Corporate as per the applicability criteria specified in the aforesaid circular for Large Corporates. Accordingly, the Disclosure and Compliances mentioned therein to be done by Large Corporates are not applicable.
15-04-2021
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as amended from time to time please find attached herewith the Compliance Certificate as received from "Link Intime India Private Limited" Registrar and Share Transfer Agent of the Company for the quarter ended March 31, 2021.
14-04-2021
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Shareholding for the Period Ended March 31, 2021

 Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
14-04-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Statement Of Investor Complaints For The Quarter Ended March 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Geeta KariraDesignation :- Company Secretary and Compliance Officer
09-04-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window

 In terms of provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company''s Code for prohibition of Insider Trading, the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (including their immediate relatives) from Thursday, April 1, 2021 till the expiry of forty-eight (48) hours after the declaration of Audited Financial Results (Standalone) of the Company for the quarter and year ended March 31, 2021.
31-03-2021
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Change in Directorate

 In terms of Regulation 30(2) read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ("the Listing Regulations"), we wish to inform you that on the recommendations of Nomination and Remuneration Committee, the Board of Directors of the Company, in their meeting held today i.e., Sunday, March 21, 2021 has inter-alia considered and approved the appointment of Dr. Praveen Saxena (DIN: 03199264) as an Additional Director (Independent Non-Executive Director) of the Company for a term of five (5) consecutive years w.e.f. March 21, 2021 subject to the approval of shareholders at the ensuing Annual General Meeting.
21-03-2021
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Outcome Of The Board Meeting Held On March 21, 2021.

 In terms of Regulation 30(2) read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ("the Listing Regulations"), we wish to inform you that on the recommendations of Nomination and Remuneration Committee, the Board of Directors of the Company, in their meeting held today i.e., Sunday, March 21, 2021 has inter-alia considered and approved the appointment of Dr. Praveen Saxena (DIN: 03199264) as an Additional Director (Independent Non-Executive Director) of the Company for a term of five (5) consecutive years w.e.f. March 21, 2021 subject to the approval of shareholders at the ensuing Annual General Meeting.
21-03-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Update In The Covering Letter Reference No. MDOL/CS-SE/2020-21/047.

 Update in the covering letter reference no. MDOL/CS-SE/2020-21/047.
11-02-2021
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Un-Audited Financial Results For The Quarter Ended December 31, 2021

 Un-Audited Financial Results for the Quarter ended December 31, 2021
11-02-2021
Next Page
Close

Let's Open Free Demat Account